Combination therapy of newly diagnosed intermediate-risk pulmonary arterial hypertension: A review
Advancements in the specific therapy of pulmonary arterial hypertension (PAH) and new combination therapy strategies and escalation treatment over the past decade have significantly improved disease control, slowed its progression, and improved quality of life and patient survival. This review provi...
Saved in:
Main Authors: | Irina N. Lyapina (Author), Tatiana N. Zvereva (Author), Tamila V. Martynyuk (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence and prevalence of pulmonary arterial hypertension associated with systemic lupus erythematosus. A systematic review
by: Vadim D. Zakiev, et al.
Published: (2024) -
HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
by: I. V. Osipova, et al.
Published: (2016) -
The Capabilities of Amlodipine/Lisinopril Single-Pill Combination in the Treatment of Newly Diagnosed Arterial Hypertension in a Middle-Aged Patient (Case Report)
by: A. I. Kochetkov, et al.
Published: (2020) -
Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension: Short and intermediate term results
by: Parag S Bhalgat, et al.
Published: (2012) -
Novel and emerging therapies in pulmonary arterial hypertension
by: Steven J. Cassady, et al.
Published: (2022)